Potential angiogenic role of platelet-activating factor in human breast cancer

American Journal of Pathology

Volumn 153, Issue 5, 1998, Pages 1589-1596

  Montrucchio, Giuseppe ^a   Sapino, Anna ^a   Bussolati, Benedetta ^a   Ghisolfi, Gianpiero ^a   Rizea Savu, Simona ^b   Silvestro, Luigi ^b   Lupia, Enrico ^a   Camussi, Giovanni ^c,d  

^a UNIVERSITY OF TURIN   (Italy)

^b 3S Pharmacol Consult/Research GmbH   (Germany)

^c UNIVERSITY OF PAVIA   (Italy)

^d Istituto di Nefro Urologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; INTERLEUKIN 1ALPHA; MATRIGEL; SCATTER FACTOR; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACTION; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; MASS SPECTROMETRY; MELANOMA; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; THIN LAYER CHROMATOGRAPHY; TUMOR VASCULARIZATION;

EID: 0031769314     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65747-1     Document Type: Article

References (62)

1. Gimbrone MA, Leapman SB, Cotran RS, Folkman J: Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972, 136: 261-276
2. Gimbrone MA, Cotran RS, Leapman SB, Folkman J: Tumor growth neovascularization: an experimental model using rabbit cornea. J Natl Cancer Inst 1974, 52:413-427
3. Folkman J, Cotran R: Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976, 16:207-215
4. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med 1995, 1:27-31
5. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336
6. Hart IR, Saini A: Biology of tumour metastases. Lancet 1991, 339: 1453-1457
7. Hanahan D, Folkman J: Pattern and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1991, 86:353-364
8. Weinstat-Saslow D, Steeg PS. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB 1994, 8:401-407
9. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991, 324:3-8
10. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Melis S, Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1991, 84:1875-1887
11. Bosari S, Lee AKD, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1991, 23:755-761
12. Toi M, Kashitani J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993, 55:371-374
13. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast-carcinoma. J Clin Oncol 1994, 12:454-466
14. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995, 147:9-19
15. Heiman R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S: Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst 1996, 88:1764-1769
16. Van Hoef ME, Knox WF, Dhesi SS, Howell A, Schor AM: Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 1993, 29A:1141-1145
17. Fox SB: Tumour angiogenesis and prognosis. Histopathology 1997, 30:294-301
18. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992, 340:1120-1124
19. Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995, 13:765-782
20. Simpson JF, Ahn C, Battifora H, Esteban JM: Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 1996, 77:2077-2085
21. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 1995, 26:1757-1763
22. Leek RD, Harris AL, Lewis CE: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukocyte Biol 1994, 56: 423-435
23. Blood CH, Zetter BR: Tumor interaction with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990, 1032: 89-118
24. Sunderskotter C, Steinbrink K, Goebeler M, Bhardway C, Sorg C: Macrophages and angiogenesis. J Leukocyte Biol 1994, 55:410-422
25. Dvorak HF, Lawrence FB, Detmar M, Dvorak A: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146:1029-1039
26. Brown L, Berse B, Jakman R, Tognazzi K, Guidi A, Dvorak H, Senger D, Connolly J, Schnitt S: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995, 28:86-91
27. Toi M, Inada K, Suzuki H, Tominaga T: Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Br J Cancer Res Treat 1995, 36:193-204
28. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP: Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 1996, 56:2013-2016
29. Anandappa SY, Winstanley JHR, Leinster S, Green B, Rudland PS, Barraclough R: Comparative expression of fibroblast growth factor mRNA in benign and malignant breast disease. Br J Cancer 1994, 69:772-776
30. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB: Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987, 48:417-428
31. Walker RA, Dearing SJ, Gallacher B: Relationship of transforming growth factor-β1 to extracellular matrices and stromal infiltrates in invasive breast carcinoma. Br J Cancer 1994, 69:1160-1165
32. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, Shin S: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994, 54:1630-1636
33. Pusztai L, Clover L, Cooper K, Starkey PM, Lewis CE, McGee JO: Expression of tumor necrosis factor and its receptors in carcinoma of the breast. Br J Cancer 1994, 70:289-292
34. Vrana JA, Stang MT, Grande JP, Getz MJ: Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor-β family. Cancer Res 1996, 56:5063-5070
35. Contino J, Hair G, Kreutzer DL, Rickles FR: In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Med 1996, 2:209-218
36. Relf M, LeJeune S, Scott PAE, Fox S, Smith K, Leek R, Moghaddan A, Withouse R, Bicknell R, Harris AL: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet derived endothelial cell growth factor, placental growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997, 57:963-969
37. McManus LM, Woodard DS, Deavers SI, Pinckard SI: PAF molecular heterogeneity: pathobiological implications. Lab Invest 1993, 69: 639-648
38. Camussi G: Interactive effects of tumor necrosis factor and platelet activating factor in the pathogenesis of glomerular injury. Lab Invest 1994, 70:435-436
39. Montrucchio G, Lupia E, Battaglia E, Passerini G, Bussolino F, Emanuelli G, Camussi G: Tumor necrosis factor induced angiogenesis depends on in situ platelet-activating factor byosynthesis. J Exp Med 1994, 180:377-382
40. Camussi G, Montrucchio G, Lupia E, Soldi R, Comoglio PM, Bussolino F: Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet activating factor synthesis from macrophages. J Immunol 1997, 158:1302-1309
41. Camussi G, Montrucchio G, Lupia E, DeMartino A, Perona L, Arese M, Vercellone A, Toniolo A, Bussolino F: Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J Immunol 1995, 154:6492-6501
42. Bussolino F, Arese M, Montrucchio G, Barra L, Primo L, Benelli R, Sanavio F, Aglietta M, Ghigo D, Rola-Pleszczynski M, Bosia A, Albini A, Camussi G: Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 1995, 96:940-952
43. Prescott SM, Zimmerman GA, McIntyre GA: Platelet-activating factor. J Biol Chem 1990, 268:17381-17384
44. Honda Z, Nakamura M, Miki I, Minami M, Watanabe T, Seyama Y, Okado H, Toh H, Ito K, Myamoto T, Shimizu T: Cloning by functional expression of platelet activating factor receptor from guinea pig lung. Nature 1991, 349:342-346
45. Pitton C, Lanson M, Besson P, Fetissoff F, Lansac J, Benveniste J, Bougnoux P: Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis. J Natl Cancer Inst 1989, 81:1298-1302
46. Im SY, Ko HM, Kim JW, Lee HK, Ha TY, Lee HB, Oh SJ, Bai S, Chung KC, Lee YB, Chun SB: Augmentation of tumor metastases by platelet-activating factor. Cancer Res 1996, 56:2662-2665
47. Lupia E, Montrucchio G, Battaglia E, Modena V, Camussi G: Role of tumor necrosis factor-a and platelet activating factor in neoangiogenesis induced by sinovial fluids of patients with rheumatoid arthritis. Eur J Immunol 1996, 26:1690-1694
48. Camussi G, Aglietta M, Malavasi F, Tetta C, Piacibello W, Sanavio F, Bussolino F: The release of platelet activating factor from human endothelial cells in culture. J Immunol 1983, 131:2397-2403
49. Bussolino F, Arese M, Silvestro L, Soldi R, Benfenati E, Sanavio F, Aglietta M, Bosia A, Camussi G: Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-α or interleukin-1α. Eur J Immunol 1994, 24:3131-3139
50. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH: Pharmacologic activity of bepafant (WEB2170), a new and selective tetrazepinoic antagonist of platelet-activating factor. J Pharmacol Exp Ther 1990, 225:962-968
51. Rizea Savu S, Silvestro L, Sorgel F, Montrucchio G, Lupia E, Camussi G: Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography by tandem mass spectrometry. J Chromatogr 1996, 628:35-42
52. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 1992, 67:519-528
53. Taub M, Wang Y, Szczesny TM, Kleinman HK: Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in Matrigel cultures in serum-free medium. Proc Natl Acad Sci USA 1990, 87:4002-4006
54. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH: Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 1992, 202:1-8
55. Santos OFP, Nigam SK: HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular matrix and TGF-β. Dev Biol 1993, 160:293-302
56. Kibbey MC, Grant DS, Klieinman HK: Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J Natl Cancer Inst 1992, 84:1633-1404
57. Triggiani M, Hubbard WC, Chilton FH: Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell. J Immunol 1990, 144:4773-4780
58. Fox SB, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG, Harris AL: Relationship of endothelial-cell proliferation to tumor vascularity in human breast cancer. Cancer Res 1993, 53:4161-4163
59. Barnes PJ, Page CP, Henson P. Platelet Activating Factor and Human Disease. London, Blackwell Scientific Publications, 1989
60. Camussi G, Bussolino F, Salvidio G, Baglioni C: Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 1987, 166:1390-1404
61. Bussolino F, Sironi M, Bocchietto E, Mantovani A: Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8. J Biol Chem 1992, 267:1498-1503
62. Nauck M, Roth M, Tamm M, Eickelberg O, Wieland H, Stulz P, Perruchoud AP: Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol 1997, 16:398-406